Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
≤0.5 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
73 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
0.5 - 4 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1056 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
1 - 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
186 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
1 - 2 |
Vancomycin (Vancocyn, Lyphocin) |
374 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
1 - 4 |
Teicoplanin (Targocid) |
178 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
1 - 4 |
Vancomycin (Vancocyn, Lyphocin) |
178 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
1 - 8 |
Eperezolid (PNU-100592) |
33 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
2 - 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
109 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
2 - 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1279 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
2 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
463 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
≤0.12 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
371 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
0.125 - 8 |
Cefepime (Maxipime) |
113 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
0.125 - 16 |
Cefotaxime (Cephotaxime, Claforan) |
113 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
0.125 - 32 |
Cefoperazone (Cefobid) |
113 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
0.5 - 4 |
Meticillin (Methicillin, Staphcillin) |
178 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
0.5 - >64 |
Cefepime (Maxipime) |
55 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 - 4 |
Cefepime (Maxipime) |
1491 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
72 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1060 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 - 8 |
Cefpodoxime |
600 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 - 8 |
Linezolid (PNU-100766, U-100766, Zyvox) |
11 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
1 - >32 |
Linezolid (PNU-100766, U-100766, Zyvox) |
55 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
2 - 4 |
Cefuroxime (Kefurox, Zinacef) |
19 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
2 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
189 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
? - ? |
Cefoperazone (Cefobid) |
1389 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
? - ? |
Cefoxitin (Mefoxin) |
1389 |
Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
? - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
36 |